The table below shows Praxis Precision Medicines, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$86.15M
-$53.01M
-$20.86M
-$32.85M
-$54.11M
-$25.72M
Capital expenditure
$62.00K
$0.00
-
$0.00
$289.00K
$4.00K
Investing cash flow
-$344.27M
-$51.06M
-$91.22M
$34.00M
-$8.55M
-$140.01M
Dividends paid
-
-
-
PRAX operating cash flow (10-K history)
Praxis Precision Medicines, Inc. reported operating cash flow of -$249.07M for fiscal year 2025. That is down 89.0% from -$131.76M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from -$33.42M (FY 2019) to -$249.07M. Figures come from the company's audited annual reports as filed with the SEC.